Appendix D

Committee Member and Staff Biographies

COMMITTEE MEMBERS

Donald Berwick, M.D., M.P.P., FRCP (London) (Chair), is the president emeritus and a senior fellow at the Institute for Healthcare Improvement and a former administrator of the Centers for Medicare & Medicaid Services. A pediatrician by background, Dr. Berwick has served on the faculty of the Harvard Medical School and the Harvard T.H. Chan School of Public Health, and on the staff of Boston’s Children’s Hospital Medical Center, Massachusetts General Hospital, and Brigham and Women’s Hospital. He has also served as the vice chair of the United States Preventive Services Task Force, the first “independent member” of the American Hospital Association Board of Trustees, and the chair of the National Advisory Council of the Agency for Healthcare Research and Quality. He served two terms on the Institute of Medicine’s (IOM’s) Governing Council, was a member of the IOM’s Global Health Board, and served on President Clinton’s Advisory Commission on Consumer Protection and Quality in the Healthcare Industry. Recognized as a leading authority on health care quality and improvement, Dr. Berwick has received numerous awards for his contributions. In 2005, he was appointed Honorary Knight Commander of the British Empire by Her Majesty Queen Elizabeth II in recognition of his work with the British National Health Service. Dr. Berwick is the author or co-author of more than 200 scientific articles and 6 books.

Jennifer Bogner, Ph.D., ABPP-Rp, FACRM, is a professor and the Bert C. Wiley, MD Endowed Chair in Physical Medicine and Rehabilitation at The Ohio State University. Dr. Bogner is the project director for the Ohio Regional Traumatic Brain Injury (TBI) Model Systems, 1 site of 16 distributed nationally and funded by the National Institute on Disability, Independent Living, and Rehabilitation Research. The TBI Model Systems have been conducting national longitudinal and interventional studies on TBI for the past 35 years, and the Ohio Regional TBI Model System has been a site since 1997. The overarching goal of Dr. Bogner’s research has been to improve long-term outcomes after TBI. Specific areas of research include using causal inference methods to evaluate the comparative effectiveness of rehabilitation interven-

tions; prevention and treatment of substance misuse following TBI; evaluating the impact of lifetime exposure to TBI on quality of life; and the development and validation of measurement tools to support rehabilitation research and clinical practice. Dr. Bogner previously chaired the Brain Injury Interdisciplinary Special Interest Group of the American Congress of Rehabilitation Medicine. She received the Roger G. Barker Distinguished Research Contribution Award from the American Psychological Association Division of Rehabilitation Psychology and the William Fields Caveness Award from the Brain Injury Association of America.

Matthew E. Fink, M.D., is the Louis and Gertrude Feil Professor and the chair of the Department of Neurology at Weill Cornell Medical College and the neurologist-in-chief, the chief of the Division of Stroke and Critical Care Neurology, and the vice chair of the Medical Board at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Fink was a founding member and the chair of the Critical Care Section of the American Academy of Neurology and the Research Section for Neurocritical Care of the World Federation of Neurology. He is board certified in internal medicine, neurology, critical care medicine, vascular neurology, and neurocritical care. He has been elected as a fellow of the American Neurological Association, the American Academy of Neurology, and the Stroke Council of the American Heart Association. Throughout his career, Dr. Fink has been involved in the education and training of students, residents, and fellows in the field of stroke and critical care neurology, as well as an active participant in clinical research within this field. He is a leader in this new specialty, having lectured widely and published numerous research and clinical articles in the field of stroke and critical care. In addition, he currently serves as the editor of the monthly publication Neurology Alert and is the past president of the New York State Neurological Society.

Jessica Gill, Ph.D., R.N., is a Bloomberg Distinguished Professor in the Schools of Nursing and Medicine at Johns Hopkins University. She previously served as a senior investigator with the National Institute of Nursing Research (NINR) at the National Institutes of Health (NIH) and as the deputy director of NINR. Dr. Gill’s current research focuses on revealing the mechanisms underlying differential responses to combat trauma and traumatic brain injury (TBI). Dr. Gill is a leader in research focused on identifying blood-based biomarkers that predict poor recovery from traumatic brain injuries, concussions, and blast. She leads biomarker methods and clinical trial design within national and international funded consortiums, and analyzes these samples in her laboratory at NIH. Specifically, Dr. Gill’s laboratory has developed novel methods to understand central processes using peripheral blood, to allow for a better understanding of the mechanisms of neuronal recovery from brain injuries. Her research combines biological methods—including proteomics and epigenetics—with neuronal imaging to follow patients during their immediate recoveries and for years afterward to better understand risk and resiliency factors related to clinical outcomes. She will be appointed as a member the National Academy of Medicine in 2022.

Odette Harris, M.D., M.P.H., is a professor of neurosurgery and the vice chair and the director of the Brain Injury Program at Stanford University. She is a fellow of the American Association of Neurological Surgeons, a member of the Congress of Neurological Surgeons, and a fellow of the Aspen Global Leadership Network. Dr. Harris manages and coordinates the medical and surgical care of patients suffering from traumatic brain injury (TBI) who are admitted to the Stanford System. She focuses on implementing and streamlining current treatment algorithms aimed at improving the outcomes of this growing population. Dr. Harris is also the deputy chief of staff of rehabilitation and the site director and the principal

investigator of the Traumatic Brain Injury Center of Excellence (TBICoE) at the VA Palo Alto Health Care System. The primary focus of TBICoE is TBI-specific evaluation, treatment, and follow-up care for all military personnel, Veterans, and their dependents.

Sidney Hinds II, M.D., Colonel (U.S. Army [Retired]), is the vice president for brain health strategy and research at the Wounded Warrior Project; the co-principal investigator and the lead for external collaborations for the Long-Term Impact of Military-Relevant Brain Injury Consortium; and a consultant with SCS Consulting, LLC. Dr. Hinds is a neurologist and a nuclear medicine physician with more than 30 years of military medical experience. He most recently served as the brain health research coordinator for the Department of Defense (DoD) Blast Injury Research Coordinating Office and as the medical advisor to the principal assistant for research and technology of the Medical Research and Materiel Command in Fort Detrick, Maryland. He was the national director of the Defense and Veterans Brain Injury Center from July 1, 2013, to March 16, 2016, collaborating, advising, and promoting military-relevant neurological and psychological medical and nonmedical research efforts within DoD and with external partners. Prior to that, he served as the deputy director of the Armed Forces Radiobiology Research Institute for Military Medical Operations, the in-theater neurology consultant in Afghanistan (Operation Enduring Freedom), and the chief of nuclear medicine services at Walter Reed National Military Medical Center.

Frederick Korley, M.D., Ph.D., is an associate professor of emergency medicine at the University of Michigan. His research is focused on the development of diagnostics and therapeutics for traumatic brain injury (TBI). Dr. Korley holds two patents for biofluid-based biomarkers for diagnosing TBI and prognosticating TBI outcome. He is the co-investigator of the largest observational study of TBI in the United States (Transforming Research and Clinical Knowledge in TBI). In collaboration with colleagues in engineering, Dr. Korley is developing a credit card–sized microfluidic device for point-of-care measurement of TBI biofluid-based biomarkers. He is also the principal investigator of two federally funded, multicenter studies run by the Strategies to Innovate Emergency Clinical Care Trials Network, investigating the use of biofluid-based biomarkers for subject selection in clinical trials and for monitoring individual patient response to promising neuroprotective agents. In addition, he is the principal investigator of a Phase II adaptive design, multicenter clinical trial funded by the National Institute of Neurological Disorders and Stroke, investigating the optimal treatment parameters of hyperbaric oxygen for treating severe TBI.

Ellen J. MacKenzie, Ph.D., M.Sc., is the dean of the Johns Hopkins Bloomberg School of Public Health. A leading expert in injury prevention and health services and outcomes research, Dr. MacKenzie was named a Bloomberg Distinguished Professor in 2017, recognizing her interdisciplinary work in trauma care and rehabilitation. She founded the Major Extremity Trauma Research Consortium, a national network of more than 50 civilian and military trauma centers. In 2018, she was elected to the National Academy of Medicine. Before becoming dean, Dr. MacKenzie held key leadership positions at the Bloomberg School, including the chair of the Department of Health Policy and Management, the director of the Center for Injury Research and Policy, and the senior associate dean for academic affairs. She has joint appointments in the Department of Biostatistics and the School of Medicine’s departments of orthopaedics, physical medicine and rehabilitation, and emergency medicine. The Centers for Disease Control and Prevention named Dr. MacKenzie one of 20 leaders and visionaries who have had a transformative effect on the field of violence and injury prevention in the past 20 years.

Geoffrey Manley, M.D., Ph.D., is the chief of neurosurgery at Zuckerberg San Francisco General Hospital (ZSFG), where he co-directs the Brain and Spinal Injury Center, and is a professor and the vice chair of neurosurgery at the University of California, San Francisco. Dr. Manley is an internationally recognized expert in neurotrauma. In addition to a robust clinical practice at ZSFG, which is San Francisco and the Greater Bay Area’s Level 1 trauma center, he coordinates and leads national and international clinical research efforts in the study of the short- and long-term effects of traumatic brain injury (TBI). Dr. Manley is the contact principal investigator and the co-founder of the Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) NETWORK, an innovative, precision medicine–driven consortium that will test Phase II TBI drugs. The TRACK-TBI studies have created a modern precision medicine information commons for TBI that integrate clinical, imaging, proteomic, genomic, and outcome biomarkers to drive the development of a new TBI disease classification system, which could revolutionize diagnosis, direct patient-specific treatment, and improve outcomes. Dr. Manley’s nearly 300 published manuscripts reflect a wide range of research interests from molecular aspects of brain injury to the clinical care of TBI. He sits on the National Academies of Sciences, Engineering, and Medicine’s Committee on VA Examinations for Traumatic Brain Injury; has served as a consultant for the World Health Organization’s Prehospital Guidelines Committee; and serves on numerous clinical research committees for the National Institutes of Health, the Centers for Disease Control and Prevention, and the Department of Defense.

Susan Margulies, Ph.D., is an assistant director of the National Science Foundation, leading the Directorate for Engineering, and a professor in the Wallace H. Coulter Department of Biomedical Engineering, jointly housed in the College of Engineering at the Georgia Institute of Technology and the School of Medicine at Emory University. She is the Georgia Research Alliance Eminent Scholar in Injury Biomechanics and previously served as the chair of the department. Using an integrated biomechanics approach consisting of relevant animal models, cell and tissue experiments, and complementary computational models and human studies, Dr. Margulies’s research has generated new knowledge about the structural and functional responses of the brain and lung to their mechanical environment. Her lab has pioneered new methods for measuring functional effects of large or repeated tissue distortions; identified injury tolerances, response cascades, and causal signaling pathways; and translated these discoveries to preclinical therapeutic trials to mitigate and prevent brain and lung injuries in children and adults. Dr. Margulies is a fellow of the American Society of Mechanical Engineers, the Biomedical Engineering Society, and the American Institute for Medical and Biological Engineering. She is a member of the National Academy of Engineering and the National Academy of Medicine. Any opinions, findings, and conclusions or recommendations expressed in this report are those of Dr. Margulies and do not necessarily reflect the views of the National Science Foundation.

Christina L. Master, M.D., is a professor of clinical pediatrics at the University of Pennsylvania Perelman School of Medicine, and a pediatric and adolescent primary care sports medicine specialist, as well as an academic general pediatrician, at the Children’s Hospital of Philadelphia (CHOP). She is board certified in pediatrics, sports medicine, and brain injury medicine, and is also an elected fellow of the American College of Sports Medicine, the American Medical Society for Sports Medicine, and the American Academy of Pediatrics. Dr. Master treats more than 800 children, youth, and young adults with concussions annually in her clinical sports medicine practice, while also continuing in her 29th year of general academic pediatric practice. She is the co-founding director of the Minds Matter

Concussion Program, a CHOP Frontier Program that provides comprehensive, cutting-edge, multidisciplinary clinical care and rehabilitation for concussion, as well as community advocacy and outreach, while advancing the field of concussion and mild traumatic brain injury in children, youth, and young adults through translational clinical research. Dr. Master’s particular research emphasis focuses on furthering understanding of visual deficits following concussion, their role in those with persistent postconcussive symptoms, and visual deficits as a target for active intervention and treatment, as well as developing objective physiological measures as quantitative biomarkers of injury and recovery.

Michael McCrea, Ph.D., is a tenured professor, an eminent scholar, and the vice chair of research in the Department of Neurosurgery at the Medical College of Wisconsin (MCW), where he also serves as the co-director for the MCW Center for Neurotrauma Research. Dr. McCrea is the past president of both the American Academy of Clinical Neuropsychology and the American Psychological Association’s Society for Clinical Neuropsychology. He has been an active researcher in the neurosciences, with hundreds of scientific publications, book chapters, and national and international lectures on the topic of traumatic brain injury (TBI). Dr. McCrea has led several large, multicenter studies on the effects of TBI and concussion. He currently is the co-principal investigator on the Concussion Assessment, Research and Education Consortium, established by the National Collegiate Athletic Association and the Department of Defense, as well as several other large-scale studies investigating the acute and chronic effects of TBI in various populations at risk. He is also a key investigator on the Transforming Research and Clinical Knowledge in TBI and TBI Endpoint Development studies. Dr. McCrea has served on several national and international expert panels related to research and clinical care for TBI over the past two decades.

Helene Moriarty, Ph.D., R.N., FAAN, is a professor and the Diane and Robert Moritz, Jr. Endowed Chair in Nursing Research at the Villanova University M. Louise Fitzpatrick College of Nursing and a nurse scientist at the Corporal Michael J. Crescenz VA Medical Center. She is also a member of the NewCourtland Center for Transitions and Health, a research center at the University of Pennsylvania School of Nursing. Dr. Moriarty’s research has led to novel insights and health care approaches for Veterans with traumatic brain injury (TBI) and their families. This research is one of the first scientific efforts to engage family members as integral partners in the care of Veterans with TBI and to address the health of family caregivers. Her completed National Institutes of Health (NIH)-funded randomized controlled trial evaluated the impact of an innovative rehabilitation intervention, the Veterans’ In-home Program (VIP), for Veterans with TBI and their families. Building on the VIP, Dr. Moriarty’s current NIH-funded research tests a rehabilitation approach that addresses critical gaps in services and research for civilians and Veterans with chronic TBI symptoms and their families. She has held leadership roles within the VA health system and serves as a member of the American Academy of Nursing’s Expert Panel on Military and Veterans Health; in 2019, she was appointed to the VA Nursing Research Field Advisory Committee charged with developing and implementing the strategic plan for nursing research for the VA health system.

Corinne Peek-Asa, Ph.D., is the vice chancellor for research at the University of California, San Diego (UCSD). She was formerly the Lowell Battershell University Distinguished Professor and the associate dean for research for the University of Iowa College of Public Health. She served on the faculty of the University of California, Los Angeles, until 2001, served on the University of Iowa faculty until 2021, and joined UCSD in 2022. Dr. Peek-Asa’s area of expertise is injury and violence prevention, including global road traffic safety, interpersonal

violence, workplace violence, and acute care. Her work has addressed the full spectrum of mild to severe traumatic brain injuries (TBIs), from prevention to outcomes. She has conducted research on the impact of gender on TBI outcomes and the impact of trauma systems on TBI patients reaching definitive care. She served on the Big Ten-Ivy League Concussion Taskforce, including the data committee. Dr. Peek-Asa has conducted international TBI research, including a role as the principal investigator on a project with the National Institutes of Health and the National Institute of Neurological Disorders and Stroke that established prospective TBI registries in four countries. She was elected to the National Academy of Medicine in 2020.

Thomas M. Scalea, M.D., is the physician-in-chief at the R Adams Cowley Shock Trauma Center at the University of Maryland. As the director, he serves at the level of chair within the school and hospital. As the physician-in-chief, he is responsible for clinical care in all medical administrative functions of the Shock Trauma Center. Under Dr. Scalea’s leadership, the Center’s faculty is responsible for the bulk of emergency general surgery patients at the University of Maryland Medical Center. His group has built a region-wide critical care program and is now responsible for 9 intensive care units and more than 100 beds. Additionally, Dr. Scalea has reorganized both research and education in the Program in Trauma. He established the G.O. Team, a rapid response team consisting of an anesthesiologist, surgeon, critical care medicine specialist, and certified registered nurse anesthetist. The G.O. team serves as a specialized component of Maryland’s statewide emergency medical system to expedite critical care interventions. In 2008 and 2011, Dr. Scalea traveled to Iraq and Afghanistan to observe the Wounded Warrior Care System and provide recommendations on how to improve the system, as well as to determine how to continually refine trauma training. He also served as the senior visiting surgeon at the Landstuhl Regional Medical Center, providing care for injured soldiers as they were evacuated from Iraq.

Eric B. Schoomaker, M.D., Ph.D., FACP, Lieutenant General (U.S. Army [Retired]), was the 42nd U.S. Army surgeon general/commanding general of the U.S. Army Medical Command prior to his retirement in 2012. He then served as a professor and the vice chair for leadership, centers, and programs in the Department of Military and Emergency Medicine at the Uniformed Services University of the Health Sciences; he is currently an emeritus professor, having retired in 2019. Dr. Schoomaker promotes complementary and integrative health and medicine in the shift from a disease management–focused health care system to a system focused on the improvement of health and well-being, as well as leadership education. His assignments included command of the Walter Reed Army Medical Center and the Eisenhower Army Medical Center; two Army regional medical commands; and the Army’s Medical Research and Materiel Command at Fort Detrick, Maryland. Dr. Schoomaker has received numerous military awards, including those from France and Germany; the 2012 Dr. Nathan Davis Award from the American Medical Association for outstanding government service; an honorary doctorate of science from Wake Forest University; a doctorate of letters in medicine from the Baylor College of Medicine; and the Philipp M. Lippe Award from the American Academy of Pain Medicine for outstanding contributions to the social and political aspect of pain medicine. He currently works part-time as a senior physician advisor to the Veterans Health Administration.

Martin Schreiber, M.D., is a professor of surgery; the chief of the Division of Trauma, Critical Care, and Acute Care Surgery; and the director of the Donald D. Trunkey Center for Civilian and Combat Casualty Care at Oregon Health & Science University. He is an

adjunct professor of surgery at the Uniformed Services University of the Health Sciences. He is also a colonel in the U.S. Army Reserve. Dr. Schreiber’s training includes significant military instruction and practice, including direct clinical experience as a military surgeon in Afghanistan. Dr. Schreiber has served as the director of the Joint Theater Trauma System for Iraq and Afghanistan. He also serves as a subject-matter expert on several Department of Defense committees, including the Committee on Surgical Combat Casualty Care (since 2016); the Tactical Combat Casualty Care Subject Matter Expert Panel (since 2018); and, as chair, the Committee on Surgical Combat Casualty Care (since 2019). Dr. Schreiber is the head of the Trauma Research Laboratory. He has been awarded the lifetime achievement award in trauma resuscitation science by the American Heart Association and the Asmund S. Laerdal Memorial Award for extensive involvement in resuscitation research and publishing from the Society of Critical Care Medicine.

Monica S. Vavilala, M.D., directs the Harborview Injury Prevention and Research Center (HIPRC), one of nine injury control centers funded by the Centers for Disease Control and Prevention; she is the only anesthesiologist in the country to hold this position. She is also a professor with tenure of anesthesiology and pain medicine and pediatrics and an adjunct professor of neurological surgery, radiology, and health services at the University of Washington. Dr. Vavilala has clinical expertise in neuroanesthesiology, pediatric trauma, and acute care of patients with traumatic brain injury (TBI). She is a translational TBI researcher and works from bench to bedside to improve care and outcomes after TBI. Dr. Vavilala co-founded the injury and health equity initiative at HIPRC and aims to improve outcomes for groups at greatest risk of injury, including children, the elderly, the poor, underrepresented minorities, and residents of rural areas. She serves on the adult and pediatric Brain Trauma Foundation Guidelines Committees. Dr. Vavilala has received funding from the National Institutes of Health for more than 20 years and has published more than 350 peer-reviewed papers.

NATIONAL ACADEMY OF MEDICINE FELLOW IN OSTEOPATHIC MEDICINE

Julieanne P. Sees, DO, FAAOS, FAOA, FAOAO, is a pediatric neuro-orthopaedic surgeon with dual fellowship training in pediatric orthopaedics and neuro-orthopaedic surgery who has focused care for children and young adults with neuromuscular conditions and chronic brain disease. An active member of the osteopathic medical profession, Dr. Sees serves on the American Osteopathic Association Board of Trustees, the American Osteopathic Foundation Board of Directors, and the American Osteopathic Academy of Orthopedics. She also serves as the president of the Delaware State Osteopathic Medical Society and the webmaster for the American Academy for Cerebral Palsy and Developmental Medicine. She teaches all levels of both osteopathic and allopathic medicine with academic affiliate professorships at the Campbell University Jerry M. Wallace School of Osteopathic Medicine, the Rowan University College of Osteopathic Medicine, and the Midwestern University Chicago College of Osteopathic Medicine. Dr. Sees has authored more than 65 peer-reviewed publications and book chapters and made more than 180 national and international conference presentations and instructional courses. Her scientific and health care advocacy research includes best practices within neuro-orthopaedics and developmental disorders, complex motor conditions and gait abnormalities, physician professional development, clinician well-being, and emerging leadership in health and medicine. Dr. Sees was named an emerging leader of

both the American Osteopathic Foundation and the Chicago College of Osteopathic Medicine Alumni Association and a fellow of both the American Orthopedic Association and the American Osteopathic Academy of Orthopedics. She obtained her B.A. in chemistry/religious studies as a Division I scholarly athlete from the College of the Holy Cross, earned her M.D. from the Midwestern University Chicago College of Osteopathic Medicine, and completed an orthopaedic residency at the former University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine.

STAFF

Katherine Bowman, Ph.D. (Study Director), is a senior program officer with the Board on Health Sciences Policy. Her activities focus on the implications of developments in science and technology. Dr. Bowman served as the co-director of the report Heritable Human Genome Editing (2020), with colleagues at The Royal Society, and as the director of the 2017 report Human Genome Editing: Science, Ethics, and Governance. Other recent studies in which she was involved include Biodefense in the Age of Synthetic Biology (2018) and Microbiomes of the Built Environment: A Research Agenda for Indoor Microbiology, Human Health, and Buildings (2017). Dr. Bowman also takes part in international activities that explore advances in science and their potential impacts for biological and chemical security. She received her Ph.D. in biomedical engineering from Johns Hopkins University.

Clare Stroud, Ph.D., is a senior program officer with the National Academies of Sciences, Engineering, and Medicine. In this capacity, she serves as the director of the Forum on Neuroscience and Nervous System Disorders, which brings together leaders from government, academia, industry, and nonprofit organizations to discuss key challenges and emerging issues in neuroscience research, development of therapies for nervous system disorders, and related ethical and societal issues. She recently served as the director of reports titled Meeting the Challenge of Caring for Persons Living with Dementia and Their Care Partners and Caregivers: A Way Forward and Preventing Cognitive Decline and Dementia: A Way Forward and as the senior program officer for the report Medications for Opioid Use Disorder Save Lives. Dr. Stroud first joined the National Academies as a science and technology policy graduate fellow. She has also been an associate at AmericaSpeaks, a nonprofit organization that engaged citizens in decision making on important public policy issues. Dr. Stroud received her Ph.D. from the University of Maryland, College Park, with research focused on the cognitive neuroscience of language. She received her bachelor’s degree from Queen’s University in Canada and spent 1 year at the University of Salamanca in Spain.

Chanel Matney, Ph.D., is a program officer with the Forum on Neuroscience and Nervous System Disorders. She also serves as the mentorship and professional development coordinator with the National Science Policy Network, a virtual community of early-career scientists and engineers that provides its members with access to resources, funding, opportunities, and programmatic support on issues related to science policy and advocacy. Dr. Matney has served as an intern, an analyst, and a fellow with various science and technology policy nonprofits. She has served as a California Council of Science and Technology science fellow, working on education policy, and as a committee staffer in the California state legislature, working on transportation issues. Her thesis work mapped the organization of cortical circuits using anatomical tracing and electrophysiology. As a graduate student, she co-founded the Johns Hopkins Science Policy Group, an organization that helps early-career researchers advocate for science-informed decision making in city, state, and federal government. She

earned her doctorate in neuroscience from Johns Hopkins University as a National Science Foundation graduate predoctoral research fellow.

Bridget Borel is an administrative assistant and the program coordinator with the Board on Health Sciences Policy at the National Academies of Sciences, Engineering, and Medicine. In addition to providing program support, she helps manage the board’s contracts and staff. Ms. Borel has a wide array of writing and research experience. She wrote presidential correspondence for President Clinton on a portfolio including agriculture, science and technology, and military issues. From the White House Executive Office of the President, she joined the National Academies’ Board on Life Sciences, where she worked for 3 years before shifting into freelance writing, research, and media analysis. She serves as the communications director for her chapter of Team Red, White, and Blue, a Veteran support organization that aims to support Veterans’ mental and physical health by forging positive connections between Veterans and their communities. She earned a B.S. in biology from Tulane University.

Eden Neleman is a senior program assistant with the Forum for Neuroscience and Nervous System Disorders. Prior to joining the National Academies in the summer of 2021, Ms. Neleman volunteered at Hassenfeld Children’s Hospital at New York University Langone Health in the art therapy department; was an assistant to family psychologist Dr. Christina Cohen; and worked at WellBe, a company focused on natural health care. Throughout her studies, Ms. Neleman has been passionate about the bridge between mental and physical health and is hoping to further explore this topic at the National Academies. She earned her bachelor’s degree in psychology and art history, with a minor in child and adolescent mental studies from the Gallatin School of Individualized Study at New York University.

Andrew M. Pope, Ph.D., is the senior director of the Board on Health Sciences Policy, having been a member of the National Academies of Sciences, Engineering, and Medicine staff since 1982 and the Health and Medicine Division (HMD) staff since 1989. His primary interests are science policy, biomedical ethics, and environmental and occupational influences on human health. During his tenure at the National Academies, Dr. Pope has directed numerous studies on topics that range from injury control, disability prevention, and biologic markers to the protection of human subjects of research, National Institutes of Health priority-setting processes, organ procurement and transplantation policy, and the role of science and technology in countering terrorism. Since 1998, Dr. Pope has served as the director of the Board on Health Sciences Policy, which oversees and guides a program of activities intended to encourage and sustain the continuous vigor of the basic biomedical and clinical research enterprises needed to ensure and improve the health and resilience of the public. Ongoing activities include forums on neuroscience, genomics, drug discovery and development, and medical and public health preparedness for disasters and emergencies. Dr. Pope received HMD’s Cecil Award and the National Academy of Sciences President’s Special Achievement Award. He has a Ph.D. in physiology and biochemistry from the University of Maryland.

Sharyl Nass, Ph.D., serves as the senior director of the Board on Health Care Services, which undertakes scholarly analysis of the organization, financing, effectiveness, workforce, and delivery of health care, with emphasis on quality, cost, and accessibility. She is also the director of the National Academies’ National Cancer Policy Forum, which examines policy issues pertaining to the entire continuum of cancer research and care. For more than two decades, Dr. Nass has worked on a broad range of health and science policy topics that include the quality and safety of health care and clinical trials, developing technologies

for precision medicine, and strategies for large-scale biomedical science. She has received the Cecil Medal for Excellence in Health Policy Research, a Distinguished Service Award from the National Academies, the Mentor Award from the Health and Medicine Division, and the Institute of Medicine Staff Team Achievement Award (as team leader). Dr. Nass has a Ph.D. in cell biology from Georgetown University and undertook postdoctoral training at the Johns Hopkins University School of Medicine, as well as a research fellowship at the Max Planck Institute in Germany. She also holds a B.S. and an M.S. from the University of Wisconsin–Madison.